KEGG    Network variation - Alzheimer disease
[ Network menu | Network entry | Help ]
ENTRYnt06460
NameAlzheimer disease
CategoryDisease view; Neurodegenerative disease
Pathwayhsa05010 Alzheimer disease
DiseaseH00056 Alzheimer disease
Display drug-target relation   disease type
Calcium signaling
N00984      Glutamate→GRM5→GNAQ→PLCB→IP3→ITPR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS=APAF1→CASP9→(CASP3,CASP7)
  D1,D2,D3
 |
                          
N01002    APP*→Abeta→GRM5→GNAQ→PLCB→IP3→ITPR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS=APAF1→CASP9→CASP3
N01008              PSEN1*→ITPR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS
N01007              (PSEN1*,PSEN2*)→RYR3→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS=APAF1→CASP9→(CASP3,CASP7)
N01000      ACh→mAChR→GNAQ→PLCB→IP3→ITPR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS
  D1,D2,D3
 |
                    
N01001    APP*→Abeta→mAChR→GNAQ→PLCB→IP3→ITPR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS
N00967              Ca2+(extracellular..−VGCC→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS=APAF1→CASP9→(CASP3,CASP7)
          D1,D2,D3
 |
            
N01004            APP*→Abeta→VGCC(L-type)→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS
                D1,D2,D3
 |
      
N01006                  APP*→Abeta→PPID→MPTP→CYCS
N00970              Glutamate→NMDAR→Ca2+
          D1,D2,D3
 |
            
N01003            APP*→Abeta→NMDAR→Ca2+−MCU→Ca2+(mito)−MPTP→CYCS
 
Ubiquitin-proteasome system
N01029      (Protein+UB)−26S→Peptide
  D1,D2,D3
 |
  
N01060    APP*→Abeta⊣26S
 
Unfolded protein response (UPR) signaling
N01009      EIF2AK3→EIF2S1→ATF4⇒DDIT3
N01010    PSEN1*⊣EIF2AK3→EIF2S1→ATF4⇒DDIT3
N01011      ERN1→XBP1⇒DDIT3
N01012    PSEN1*⊣ERN1→XBP1
N01013    ERN1→TRAF2→MAP3K5→MAP2K7→JNK
  D1,D2,D3
 |
      
N01014    APP*→Abeta→MAP3K5→MAP2K7→JNK
N01015      ATF6⇒(DDIT3,XBP1,HSPA5)
N01016    PSEN1*⊣ATF6⇒(DDIT3,XBP1)
 
Apoptosis
N00146      (FASLG,TNFSF10)→(FAS,TNFRSF10B)→FADD→(CASP8,CASP10)→BID→(BAX,BAK1)→CYCS=APAF1→CASP9→(CASP3,CASP7)
  D1,D2,D3
 |
                  
N01005    APP*→Abeta→FAS→FADD→CASP8→BID→(BAX,BAK1)→CYCS=APAF1→CASP9→CASP3
 
AGE-RAGE signaling
N00994      AGE→AGER→RAS→RAF→MEK→ERK→NFKB⇒(TNF,IL6,NOS2)
  D1,D2,D3
 |
              
N00996    APP*→Abeta→AGER→RAS→RAF→MEK→ERK→NFKB⇒(TNF,IL6,NOS2)
 
Oxidative phosphorylation
N00995                  NADH−CxI→Q
  D1,D2,D3
 |
                
N00997    APP*→Abeta→CHRNA7→Ca2+→CAPN→CDK5R1=CDK5→MAPT⊣CxI→Q
N00988    Succinate−CxII→QH2
N01402    Mn2+⊣CxII→QH2
N00998      CytC−CxIV→H2O
  D1,D2,D3
 |
    
N00999    APP*→Abeta⊣CxIV→H2O
 
Microtubule-based transport
N00978                  (KIF5+KLC)=(TUBA+TUBB)
N01017              PSEN1*→GSK3B⊣(KIF5+KLC)
  D1,D2,D3
 |
              
N01018    APP*→Abeta→CHRNA7→Ca2+→CAPN→CDK5R1=CDK5→MAPT⊣(TUBA+TUBB)
N01403              Zn2+→GSK3B→MAPT⊣(TUBA+TUBB)
N01414              Fe2+→CDK5→MAPT⊣(TUBA+TUBB)
 
Environmental pollutant
    D1,D2,D3
 |
N01415      NEP⊣Abeta
N01416    Hg⊣NEP


Drug name
D1D10541Aducanumab (USAN)
D2D11500Donanemab (USAN/INN)
D3D11678Lecanemab (USAN)